

18983288589(微信同号)

18983288589(微信同号)

18908392210(微信同号)

18980413049
ChiCTR2100045939
正在进行
/
/
/
2021-04-29
/
/
Parkinson's disease
A randomized trial on the comparative effects of 'mindfulness in stillness' versus 'mindfulness in motion' on physio-psycho-spiritual wellbeing in people with Parkinson's disease
‘Mindfulness in stillness' or 'mindfulness in motion'? A randomized controlled trial on the effects and acceptability of individual mindfulness techniques – meditation and yoga – on anxiety and depression in people with Parkinson's disease
To examine the comparative effects of mindfulness of stillness versus ‘mindfulness of motion’ on psychological distress, motor symptoms, non-motor symptoms, mobility and gait, mindfulness attitude, and HRQOL of PD individuals, compared with usual care control.
随机平行对照
其它
All eligible participants will be assigned with a sequential participant number. A computer-generated randomization sequence will be generated, participants will be assigned to either one of the three groups by an independent research assistant.
All outcome assessors will be blinded to subject allocation.
General Research Fund, University Grants Committee
/
56
/
2021-05-04
2022-12-31
/
1. Diagnosed with idiopathic PD (Hoehn and Yahr stage I-III); 2. Aged >=18 years; 3. Able to stand unaided and walk with or without an assistive device; 4. Able to give written consent.;
登录查看1. Have been regularly practicing instructor-led mind-body interventions such as meditation, yoga, Tai Chi, Qigong, or dance once a week or more during the past 6 months; 2. Are currently participating in any other behavioural or pharmacological trial; 3. Have cognitive impairment as indicated by the abbreviated mental test lower than 6; 4. Have serious medical conditions except PD, or other contraindication to mild-to-moderate physical exertion that might limit their full participation (e.g. severe hearing or vision impairment, significant orthopaedic problems, etc.).;
登录查看N/A
/
康方生物Akeso2025-04-23
医麦客2025-04-23
医麦创新药2025-04-22
药筛2025-04-22
药研网2025-04-22
上海宝济药业股份有限公司2025-04-22
抗体圈2025-04-22
抗体圈2025-04-22
贵州卡尔细胞生物2025-04-22